The FICOH Charitable Foundation has donated $125,000 to support the UH Cancer Center’s new state-of-the-art Early Phase Clinical Research Center. This center will provide access to phase 1 clinical trials for cancer patients in Hawaiʻi so they do not have to travel to the continental U.S. for specialized treatments.
Jeff Shonka said, “As a Hawai‘i company and employer, we feel it is imperative for us to invest in research that will have tangible benefits for our community. So many people in Hawaii are personally impacted by cancer each year. This is our way of helping find new lifesaving treatments and therapies for our families, neighbors and friends."
In thanking FICOH for their generous support, Dr. Randall Holcombe, UH Cancer Center director said, “Phase 1 clinical trials represent the cutting edge of cancer treatments and are often considered when patients have a particularly challenging form of cancer or when standard treatments have been unsuccessful.” Holcombe continued, “In a state where approximately 7,100 people are diagnosed each year with cancer, the stakes are high, and we are so grateful to FICOH for their commitment to our center and the state.”